Carlyle Acquires 20% Stake in India’s Piramal Pharma for USD490m
Source(s): The Carlyle Group
The Carlyle Group has agreed to acquire a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises for USD490m. Read more
Source(s): The Carlyle Group
The Carlyle Group has agreed to acquire a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises for USD490m. Read more